
Checkpoint Therapeutics, Inc.
Checkpoint Therapeutics, Inc. (CKPT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CKPT · as of Jun 9, 2026
Key Statistics
Explore Checkpoint Therapeutics, Inc. Data
ckpt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 71.4%
The CKPT analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $4.10, representing -3.76% downside from the current price of $4.26.
Competitors & Peers
ckpt competitorsStock Performance
Full HistoryAbout Checkpoint Therapeutics, Inc.
Checkpoint Therapeutics, Inc. is a clinical-stage company specializing in immunotherapy and targeted oncology. Its mission involves discovering, advancing, and bringing to market innovative therapeuti…
what is checkpoint therapeutics, inc. · ckpt stock overview · checkpoint therapeutics, inc. company profile · who is checkpoint therapeutics, inc. ceo · ckpt NASDAQ · checkpoint therapeutics, inc. headquarters · checkpoint therapeutics, inc. business segments
About Stock Overview & Key Data
Checkpoint Therapeutics, Inc. (CKPT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 19, 2016. As of the latest trading session, CKPT stock price is $4.26, with a market capitalization of $367.7M. The stock has returned +107.80% over the past 12 months and +29.48% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Checkpoint Therapeutics, Inc. stock is Buy, with an average 12-month price target of $4.10. In fiscal year 2024, Checkpoint Therapeutics, Inc. reported revenue of $41000.00 and net income of -$56.2M. For detailed data — including Checkpoint Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Checkpoint Therapeutics, Inc. (CKPT) stock price is $4.26. The stock is traded on NASDAQ under the ticker symbol CKPT. The 52-week range is $1.80 – $4.50.